• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:史长城,李晴宇,朱洁瑾,林能明.新型冠状病毒肺炎疫苗的临床试验研究进展[J].中国现代应用药学,2021,38(21):2748-2753.
SHI Changcheng,LI Qingyu,ZHU Jiejin,LIN Nengming.Research Progress of Clinical Trial in COVID-19 Vaccines[J].Chin J Mod Appl Pharm(中国现代应用药学),2021,38(21):2748-2753.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1310次   下载 632 本文二维码信息
码上扫一扫!
分享到: 微信 更多
新型冠状病毒肺炎疫苗的临床试验研究进展
史长城1,2, 李晴宇2, 朱洁瑾2, 林能明1,2
1.浙江大学医学院附属杭州市第一人民医院浙江省临床肿瘤药理与毒理学研究重点实验室, 杭州 310006;2.浙江大学医学院附属杭州市第一人民医院药学部, 杭州 310006
摘要:
新型冠状病毒肺炎(COVID-19)大流行推动了COVID-19疫苗的研发速度。目前,已有99个COVID-19疫苗处于临床评价阶段,其中22个已进入临床III或IV期,许多疫苗已获紧急使用授权。本文对COVID-19疫苗的临床试验开展情况进行综述,旨在加深人们对COVID-19疫苗有效性和安全性的认识。
关键词:  新型冠状病毒肺炎  疫苗  临床试验
DOI:10.13748/j.cnki.issn1007-7693.2021.21.019
分类号:R18
基金项目:浙江省医学重点学科建设计划(浙卫办[2018]2号);浙江省卫生健康科技计划项目(2021KY237);杭州市农业与社会发展项目(20201203B214)
Research Progress of Clinical Trial in COVID-19 Vaccines
SHI Changcheng1,2, LI Qingyu2, ZHU Jiejin2, LIN Nengming1,2
1.Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou 310006, China;2.Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Department of Pharmacy, Hangzhou 310006, China
Abstract:
The threat of the COVID-19 pandemic is accelerating the development of vaccines. Currently, a total of 99 COVID-19 vaccines are undergoing clinical evaluation, 22 of these are in Phase III or IV and several vaccines have been approved for emergency use. This study provides an overview of the clinical trials of the COVID-19 vaccines, in order to provide a deep insight into the effectiveness and safety of COVID-19 vaccines.
Key words:  COVID-19  vaccines  clinical trial
扫一扫关注本刊微信